Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 212
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

The Down Low: Curbing the HIV Epidemic in Rural Louisiana

African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...

Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?

Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...

Mapping Addiction

Addiction and drug dependence are preventable and treatable diseases. Understanding the neurophysiological...

Backer Badge Funded